MARSHALL & POPP, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biopharmaceutical manufacturer.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Oct 20, 2025

Bills named in this filing 2

Lobbying activity 1

Medicare/Medicaid

Issues related to pain management, including S.475/H.R. 1227 - Alternatives to PAIN Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.